Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The report highlights a steady recovery in consumer spending during the Spring Festival, with significant increases in payment transactions and retail sales compared to the previous year [4][26] - The report emphasizes the importance of high-quality companies in high-growth sectors driven by emotional consumption themes [7][35] Summary by Sections Industry Dynamics - The Spring Festival saw a robust recovery in social consumption, with payment transactions on New Year's Eve reaching 4.931 billion, a 21.64% increase from the previous year [4][26] - Key regions like Hainan and cities such as Tianjin and Zhenjiang showed strong performance in retail and dining, with Hainan's duty-free shopping amounting to 1.03 billion yuan, up 20.9% year-on-year [4][27] - Domestic travel orders surged by 60%, and outbound travel orders increased by over 180% during the holiday period [4][26] Investment Recommendations - Investment Theme 1: Focus on high-end gold and fashion jewelry brands, recommending companies like Laopai Gold and Chaohongji for their differentiated product offerings [7][35] - Investment Theme 2: Emphasize retail companies adapting to trends and AI-enabled cross-border e-commerce leaders, with recommendations for Yonghui Supermarket and Aiyingshi [7][35] - Investment Theme 3: Highlight domestic beauty brands that cater to emotional value and innovative safe ingredients, recommending brands like Maogeping and Proya [7][35] - Investment Theme 4: Focus on differentiated medical beauty product manufacturers and leading medical beauty institutions, recommending companies like Meilitiantian Medical Health and Aimeike [7][35] Market Performance - The retail and social service indices reported declines of 1.59% and 0.78% respectively during the week from February 9 to February 13, 2026 [6][15] - The report notes that the education sector saw the highest growth among sub-sectors, while the watch and jewelry sector led the year-to-date performance with an 11.29% increase [6][18] Company Highlights - Laopai Gold reported a significant revenue increase of 250.9% in the first half of FY2025, driven by strong consumer demand and brand expansion [37] - Chaohongji is expected to achieve a net profit growth of 125% to 175% in FY2025, supported by its differentiated product strategy [37] - Maogeping and Proya are highlighted for their strong performance in the beauty sector, with Maogeping achieving a revenue increase of 31.3% in FY2025 [37]

社会服务 2026 年 02 月 22 日 投资评级：看好（维持） 行业走势图 数据来源：聚源 -12% 0% 12% 24% 2025-02 2025-06 2025-10 社会服务 沪深300 相关研究报告 | 《Spotify2026Q1 指引乐观，海南高端 | | --- | | 酒 旅 消 费 势 头 强 劲 — 行 业 周 报 》 | | -2026.2.15 | | 《国产 AI 应用访问量攀升，关注卡位 | | 瘦 身 需 求 产 品 潜 力 — 行 业 周 报 》 | | -2026.2.1 | | 《锅圈开启"四店齐发"布局，茶饮 | | 龙头强者恒强 — 行业周报》 | | -2026.1.25 | 春节海南高端消费保持快增，iphone 17 Pro Max、黄 金等品类二手交易持续升温 ——行业周报 | 初敏（分析师） | 李睿娴（分析师） | 程婧雅（分析师） | | --- | --- | --- | | chumin@kysec.cn | liruixian@kysec.cn | chengjingya@kysec.cn | | 证书编号：S0790522080008 | 证书 ...

Group 1 - The year 2025 saw significant commercial events that reflect changing consumer expectations and corporate accountability [2] - Companies faced backlash for safety and quality issues, highlighting the need for improved internal processes and transparency [3][4][8][10][11][12][19] - The shift in consumer power emphasizes the importance of brands respecting public sentiment and adapting to a more transparent market environment [21][22] Group 2 - 吉祥航空 faced criticism for distributing expired snacks, revealing serious lapses in food safety protocols and poor crisis management [3][4] - 千禾's "zero-additive" soy sauce controversy raised questions about product labeling and consumer trust, leading to a re-evaluation of marketing strategies [5][6][7] - The charging battery industry experienced a safety crisis with 罗马仕 recalling over 490,000 units due to fire risks, contrasting with 安克创新's swift response [8][9] - 白象's "half bag" noodle marketing was criticized for misleading consumers about product quantity, resulting in a rebranding effort [9][10] - 华熙生物 and 巨子生物 engaged in a public dispute over product claims, damaging both brands' reputations in the competitive beauty market [10][11] - 爱康国宾 faced a public relations disaster after a client revealed a serious misdiagnosis, leading to widespread criticism of the commercial health screening industry [11][12] - 理想汽车's marketing stunt involving a crash test video backfired, leading to public skepticism and a necessary apology [12][13][14] - 桃李面包's controversial advertising campaign resulted in a public backlash, but the company's transparent response turned the situation into a positive PR opportunity [15][16] - 西贝's struggle with public perception regarding the use of pre-prepared ingredients led to significant operational changes and store closures [17][18] - 始祖鸟's environmentally insensitive marketing stunt sparked outrage among its core audience, prompting a public apology and highlighting the importance of brand values [19][20]

智通财经APP获悉，国金证券发布研报称，奢侈品、高端香化、高端零售业绩修复加速，高净值人群消 费恢复或是高端消费改善的主要原因。该行认为，当前中国高端消费筑底效应已经展现，短期内高端消 费修复需依靠高净值人群的财富效应与针对中产的政策刺激。中长期看，需关注收入和就业的系统性改 善、房地产的企稳回升，以及财富效应从高净值人群向中产的扩散节奏。高端消费实际需求改善+供给 相对稀缺+政策效果强，重点推荐免税、黄金珠宝行业。 国金证券主要观点如下： 免税：低基数，强政策红利，高端消费修复，有望带动免税行业重回增长 免税是进口化妆品、奢侈品等高档消费品流通的重要渠道，将极大受益于高端消费恢复。海南自由贸易 港正式启动封关，有望对海南本地以及全国的免税业务产生明显的影响，叠加高端消费复苏趋势持续演 绎，影响逻辑有望超预期。此外，日本旅游热度下滑后，海南成为新热门目的地。去哪儿旅行、携程等 平台数据显示，截至2月初，春节假期目的地为海南的日均机票订单量同比增长超45%。 中国中免：公司基本面回暖，从内需看，高端消费的恢复是免税行业复苏的基础，免税行业存在整体性 机会；从外需看，入境游客的消费潜力，并未被市场充分认识，预期中 ...

前十大沽空偏离值排行 | 股票名称 | 沽空金额 | 沽空比率 | 偏离值↓ | | --- | --- | --- | --- | | 腾讯控股-R(80700) | 718.87 万元 | 95.69% | 46.66% | | 北控水务集团(00371) | 2003.99 万元 | 51.14% | 40.88% | | 中粮家佳康(01610) | 651.78 万元 | 49.54% | 40.50% | | 百奥赛图-B(02315) | 382.66 万元 | 40.57% | 38.35% | | 巨子生物(02367) | 1733.60 万元 | 51.28% | 38.24% | | 北京汽车(01958) | 487.93 万元 | 57.02% | 37.52% | | 小米集团-WR(81810) | 352.03 万元 | 81.53% | 37.28% | | 先声药业(02096) | 610.97 万元 | 49.63% | 37.17% | | 德康农牧(02419) | 559.96 万元 | 47.79% | 36.28% | | 江南布衣(03306) | 602 ...

Core Insights - Xi'an's economy in 2025 shows "asymmetric" characteristics with a GDP exceeding 1.3 trillion yuan, returning to the top 20 cities in China, while fixed asset investment declines by 15.3% [1] - The city has announced investment attraction plans and major project layouts, which have garnered market attention [1] Investment and Economic Performance - In 2025, Xi'an's actual use of domestic capital reached 141 billion yuan, a year-on-year increase of 7.5%; actual foreign investment was 816 million USD, up 11.1%, outpacing the provincial growth rate of 4.7% [1] - The quality of foreign investment continues to improve, with foreign and Hong Kong, Macao, and Taiwan investments totaling 24.28 billion yuan, a growth of 72.1% [1] - Major multinational companies such as Samsung, Micron, and Pepsi are increasing their investments in Xi'an [1] Key Projects and Initiatives - Xi'an has developed a targeted investment guide focusing on key industrial chains, successfully attracting 105 key projects, including significant projects from BYD and China Eastern Airlines [2] - The city is revitalizing state-owned industrial platforms, with 110 state-owned industrial parks being optimized, and the issuance of public REITs and ABS projects [2] - In 2025, 103 state-owned industrial parks achieved over 5 billion yuan in revenue, with an average turnover rate of 77.66%, an increase of 13.66 percentage points from 2024 [2] Strategic Planning for Future Growth - Xi'an aims to enhance its investment attraction strategy by revising positive and negative lists to guide compliant investment practices [3] - The city plans to attract over 110 industrial chain projects and more than 510 projects with over 100 million yuan in investment by 2026 [3] - The target for actual foreign investment in 2026 is set at 816 million USD, maintaining growth at the national average level [4]

胶原蛋白填充剂因其改善面部美观的能力和非侵入性特性，正成为继玻尿酸之后又一种受追捧的医美 填充剂品类。从胶原蛋白成分来源，可分为动物源性胶原蛋白和重组胶原蛋白。从一些已上市的胶原 蛋白填充剂企业来看，销售毛利率可超过八成，但面对如此多的胶原蛋白填充剂涌入市场，行业高毛 利的趋势能否维持？ 2026.02. 13 本文字数：1655，阅读时长大约3分钟 作者 | 第一财经 林志吟 "以前是没得选，现在是不知道怎么选。"有人用这句话来形容当前的胶原蛋白填充剂市场竞争现 状。 今年以来，奇璞生物、巨子生物这两家公司相继有胶原蛋白填充剂产品拿到医疗器械三类注册证。 按照中国监管要求，玻尿酸、胶原蛋白、再生材料及其他新型注射材料需要获得国家药监局三类医疗 器械注册证。从去年以来，共有9款胶原蛋白填充剂产品顺利拿到了三类注册证，这一数量超过了过 去获批的总数。换言之，胶原蛋白三类注册证变得不那么稀缺。 "在高端医美机构与三甲医院，消费者满意度集中于'自然效果'与'维持时间'两大维度。而在下沉市 场，价格敏感型用户占比提升。核心消费群体已初步形成'年龄+问题部位+预算=适合品牌'的认知框 架。医生端作为关键决策节点，其处方 ...

麻晓勤表示，2026年西安商务系统将继续打好提振消费、外贸拓展两场硬仗。她直言"邮件千遍不如见 上一面"，今年将开展"丝路优品·出海长安"行动，统筹省市多场境内外展会，覆盖全球多个国家和地 区、十余大领域，全力支持企业开拓国际市场。 据了解，2025年西安国资系统以服务城市发展为核心、深化改革为动力，推动国有经济实现质量、规模 与效益稳步提升。截至2025年12月底，全市国有企业资产总额38342.90亿元，同比增长9.5%；所有者权 益总额9692.40亿元，同比增长5.7%，总体规模创历史新高。 对于2026年国资工作，西安市国资委副主任李义长表示，将以提升核心竞争力和增强核心功能为重点纵 深推进改革。国企重组整合将秉持"三个聚焦"核心思路，通过多维度归类推动多领域战略性重组；考核 方面实施"一企一策"分类考核，下调公共服务类企业利润考核权重，提升社会效益、科技创新等指标占 比。此外，年内将盘活资产账面价值不低于20亿元，力争市属国企研发投入强度达到2%，全年新增就 业不低于3000人，持续彰显国企的责任与担当。 中新网西安2月12日电 (记者 党田野)记者12日从西安官方获悉，去年西安商务、投资合作、国 ...

Investment Rating - The report indicates a positive outlook for the cosmetics and medical beauty sector, with strong performance compared to the market [2][3]. Core Insights - Estee Lauder reported double-digit growth in China, with net sales reaching RMB 29.35 billion, a year-on-year increase of 6%, and profits improving by 127% to RMB 1.12 billion [8][26]. - The Tmall beauty category saw a significant increase of 24% year-on-year in January 2026, indicating strong consumer demand and confidence in the market [8][29]. - The report highlights the government's focus on promoting service consumption, which is expected to drive growth in key sectors, including beauty and personal care [9][10]. Summary by Sections Industry Performance - The cosmetics and medical beauty sector outperformed the market, with the Shenwan Beauty Care Index rising by 3.7% from January 30 to February 6, 2026 [3]. - The Shenwan Cosmetics Index increased by 2.8%, outperforming the Shenwan A Index by 4.4 percentage points [3]. Company Highlights - Estee Lauder's sales in mainland China surged by 13% to RMB 6.44 billion, confirming the recovery of international beauty brands in the Chinese market [8][26]. - The report notes that the top-performing stocks in the sector included Betaini (+13.5%), Huaxi Biological (+12.0%), and Beijia Clean (+10.8%) [4]. E-commerce Insights - The report provides data on the performance of domestic brands on platforms like Douyin and Tmall, showing significant growth in GMV for several brands [20]. - For instance, the brand "毛戈平" saw a GMV increase of 298% in December 2025 [21]. Market Trends - The overall retail sales of cosmetics in December 2025 grew by 8.8%, with a total retail sales figure of RMB 465.3 billion for the year, reflecting a steady recovery in consumer spending [22][23]. - The report emphasizes the shift in consumer preferences towards personalized and high-quality products, indicating a strategic opportunity for brands to innovate [10][11].

Core Viewpoint - The medical beauty injection market is experiencing unprecedented differentiation, with high-end collagen products priced around ten thousand yuan and domestic hyaluronic acid rapidly capturing the mid-to-low-end market with over 70% market share. Domestic collagen manufacturers are caught in a strategic dilemma between engaging in price wars or restructuring their value systems [1][2]. Market Growth and Dynamics - The retail market size for medical beauty injections in China has grown from 25.7 billion yuan in 2018 to 67 billion yuan in 2023, with a compound annual growth rate (CAGR) of 21.1%, and is expected to exceed 147 billion yuan by 2027, driven by technological iterations and upgraded consumer demand for products like hyaluronic acid and collagen [1][2]. Competitive Landscape - The collagen market is characterized by a "strong at both ends, weak in the middle" structure, where imported brands dominate the high-end market with prices between 8,000 to 12,000 yuan, while numerous new entrants flood the mid-to-low-end market with prices dropping below 1,000 yuan [6][11]. Pricing and Quality Issues - The price war has led to chaotic pricing in the market, with price differences for similar products reaching three to four times. Many institutions use low-priced products for customer acquisition, resulting in poor satisfaction and damage to brand reputation [2][7]. Technological Competition - High-quality animal collagen production costs range from 800 to 1,200 yuan, while recombinant collagen can be produced for under 200 yuan, explaining the presence of low-priced products in the market. The market is currently undergoing a reassessment of collagen products [8][10]. R&D and Investment Trends - Companies like Faiman Biotech are investing significantly in R&D, with annual R&D expenditures constituting 15% to 18% of revenue, surpassing the industry average of 8%. This investment is expected to translate into technological advantages [12][16]. Regulatory and Market Changes - The regulatory environment is tightening, with increased inspections leading to production halts for non-compliant companies. The capital market is shifting focus towards companies with core technological patents and comprehensive quality control systems [15][16]. Future Outlook - The industry is expected to shift from price sensitivity to value assessment, with a need for a comprehensive evaluation system that includes raw material sourcing, production processes, and long-term safety data. The market is anticipated to stabilize as consumer awareness of safety and quality increases [15][17].